MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

92.17 -0.04 (-0.04%)
Streaming Delayed Price Updated: 1:02 PM EDT, Jul 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for... 
Via MarketMinute
Topics Supply Chain
News headline image
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)... 
Via MarketMinute
News headline image
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗
Via MarketBeat
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Death of the Quick Deal: One Year Under the New FTC and DOJ Merger Regime
As we enter the early weeks of 2026, the American corporate landscape is still adjusting to a fundamental shift in the mechanics of growth. It has been nearly one year since the most significant... 
Via MarketMinute
Topics Economy
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Edwards Comments on JenaValve Acquisition
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
As the financial markets open for the 2026 calendar year, BTIG has released its highly anticipated "Top Picks" report for the first half of the year, signaling a transition from the speculative fervor... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The 2025 Dollar Rollercoaster: A Year-End Rally Masks a Historic Annual Retreat
As the final trading bells of 2025 ring out across Wall Street, the US Dollar is staging a defiant last-minute stand. After a year defined by dizzying volatility—ranging from a massive early-year surge... 
Via MarketMinute
Topics Economy World Trade
News headline image
Edwards Lifesciences Corp (NYSE:EW) Shows Strong Technical Setup for Potential Breakout ↗
Edwards Lifesciences (EW) shows strong technicals and a high-quality consolidation pattern, suggesting a potential breakout trade setup for chart-focused investors. 
Via Chartmill
News headline image
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences (EW) Earnings Transcript ↗
Edwards Lifesciences (EW) Earnings Transcript 
Via The Motley Fool
News headline image
EDWARDS LIFESCIENCES CORP (NYSE:EW) Shows Strong Technicals and a High-Quality Breakout Setup ↗
Edwards Lifesciences (EW) stock shows strong technical momentum and a high-quality breakout setup, poised for a potential move above key resistance. 
Via Chartmill
News headline image
Goodbye Nvidia, Hello Microsoft: Halvorsen's Big Q3 Hedge Fund Pivot ↗
Andreas Halvorsen of Viking Global Investors' portfolio Q3 changes included exits from Amazon, Nvidia and Qualcomm. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
EDWARDS LIFESCIENCES CORP (NYSE:EW) Beats Q3 Estimates and Raises Full-Year Guidance ↗
Edwards Lifesciences beats Q3 earnings, raises full-year guidance on strong structural heart portfolio growth and robust TAVR & TMTT sales. 
Via Chartmill
News headline image
Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance ↗
Edwards Lifesciences stock jumped late Thursday after the medtech company boosted its 2025 outlook after beating quarterly calls. 
Via Investor's Business Daily
News headline image
Edwards Lifesciences Announces CFO Transition Plan
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive. 
Via Benzinga
News headline image
Edwards Lifesciences Reports Third Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
Via Benzinga
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story